D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Luminopia's amblyopia treatment now includes patients aged 8 to 12, expanding its previous FDA approval for ages 4 to 7. The ...

Retina World Congress 2025 unites global retina experts in Fort Lauderdale to explore cutting-edge research, surgical ...

The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on ...